. ImmunoGenInc Shares Plunge after Phase III Failure of Lead ADC in Ovarian Cancer httpow.lyUe3030nT4FSÂpic.twitter.comvT9IQ2YN7L
. @ImmunoGenInc Shares Plunge after Phase III Failure of Lead ADC in Ovarian #Cancer: http://ow.ly/Ue3030nT4FS pic.twitter.com/vT9IQ2YN7L
More From BioPortfolio on ". @ImmunoGenInc Shares Plunge after Phase III Failure of Lead ADC in Ovarian #Cancer: http://ow.ly/Ue3030nT4FS pic.twitter.com/vT9IQ2YN7L"